Small Cell Lung Cancer Limited Disease (LSCLC): Are Long Treatments With Higher Doses Really Needed? von Turgeon, G.A, Kopek, N, Souhami, L, Hirsh, V, Ofiara, L, Faria, S

Volltext

Outcomes of Adjuvant Therapy in Stage 3 Endometrial Cancer Confined to the Pelvis von Albeesh, R.M, Alfieri, J, Mansure, J.J, Turgeon, G.A, Fu, L, Arseneau, J, Jardon, K, Gilbert, L, Souhami, L

Volltext

Hypofractionation IMRT in Combined Modality Treatment for Bladder Preservation in Elderly Patients With Invasive Bladder Cancer von Turgeon, G.A, Souhami, L, Cury, F.L, Faria, S.L, Duclos, M, Sturgeon, J, Kassouf, W

Volltext

5-Year Single-Institution Experience of Single-Fraction SABR for Non-Small Cell Lung Cancer von Bouchard, M., Caron, A., Turgeon, G.A., Provencher, S., Lavoie-Gagnon, H., Amzallag, D., Soucy, I., Lemaire-Paquette, S., Plourde, M.E.

Volltext

Thoracic irradiation in 3 weeks for limited-stage small cell lung cancer: Is twice a day fractionation really needed? von Turgeon, G.A., Souhami, L., Kopek, N., Hirsh, V., Ofiara, L., Faria, S.L.

Volltext

Thoracic irradiation in 3weeks for limited-stage small cell lung cancer: Is twice a day fractionation really needed? von Turgeon, G.A., Souhami, L., Kopek, N., Hirsh, V., Ofiara, L., Faria, S.L.

Volltext